Merus

Yahoo Finance • 3 days ago

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates PINC, ODP, PRO, MRUS on Behalf of Shareholders

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 3 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger – PINC, ODP, PRO, and MRUS

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • 5 days ago

SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates EA, MRUS, BRY, SMLR on Behalf of Shareholders

NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 5 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq - EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq - BRY), Semler Scientific, Inc. (Nasdaq – SMLR)

BALA CYNWYD, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ack... Full story

Yahoo Finance • 7 days ago

Notable healthcare headlines for the week: Pfizer, Novo Nordisk and JNJ in focus

Wall Street’s broader market averages closed mixed on Friday as market participants digested the U.S. government shutdown for the third day. For the week, the Dow, S&P 500, and Nasdaq Composite advanced by 1.1%, 1.08%, and 1.32%, respecti... Full story

Yahoo Finance • 8 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRO, EA, MRUS on Behalf of Shareholders

NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 9 days ago

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger – VRNT, EA, MRUS, and The Farmers Savings Bank

NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in th... Full story

Yahoo Finance • 11 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA and MRUS on Behalf of Shareholders

NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholde... Full story

Yahoo Finance • 13 days ago

Stock Index Futures Slip as Shutdown Deadline Looms, U.S. JOLTs Report and Fed Speak Awaited

December S&P 500 E-Mini futures (ESZ25 [https://www.barchart.com/futures/quotes/ESZ25]) are down -0.23%, and December Nasdaq 100 E-Mini futures (NQZ25 [https://www.barchart.com/futures/quotes/NQZ25/overview]) are down -0.14% this morning a... Full story

Yahoo Finance • 13 days ago

EQT Life Sciences portfolio company Merus to be acquired by Genmab in an all-cash USD 8.0 billion transaction

Genmab has entered into a definitive agreement to acquire Merus in an all-cash transaction for a total consideration of USD 8.0 billion, making it one of the largest acquisitions of a European biotech company to date Merus is a clinical-st... Full story

Yahoo Finance • 13 days ago

Stocks Finish Higher as Bond Yields Slip and Chip Makers Climb

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.26%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.15%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.44%.  December E-mini S&P futures (ESZ25) rose +0.24%, and Decem... Full story

Yahoo Finance • 13 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA, MRUS, BRY, SMLR on Behalf of Shareholders

NEW YORK, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to sharehold... Full story

Yahoo Finance • 13 days ago

Stocks Climb on Lower Bond Yields and Strength in Chip Makers

The S&P 500 Index ($SPX) (SPY) today is up +0.42%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.04%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.85%.  December E-mini S&P futures (ESZ25) are up +0.41%, and December E-mini N... Full story

Yahoo Finance • 13 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq – EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq – BRY), Semler Scientific, Inc. (Nasdaq – SMLR)

BALA CYNWYD, Pa., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ac... Full story

Yahoo Finance • 13 days ago

Stocks making the biggest moves midday: CSX, Electronic Arts, Pony AI, Merus & more

Check out the companies making the biggest moves midday: CSX — the railroad operator rose more than 3% after it named Steve Angel chief executive , replacing Joe Hinrichs. The management shake-up follows pressure by activist investor Ancor... Full story

Yahoo Finance • 13 days ago

Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus

Genmab, on Monday, announced its plan to buy Merus for about $8 billion. The news sent Merus stock into the stratosphere. Continue Reading View Comments... Full story

Yahoo Finance • 13 days ago

Genmab Makes $8 Billion Bet On Merus With Potential Cancer Breakthrough

Genmab A/S (NASDAQ: GMAB) on Monday agreed to acquire Merus N.V. (NASDAQ: MRUS) with its late-stage asset petosemtamab, which is in Phase 3 development, for $97 per share in an all-cash transaction representing a transaction value of appro... Full story

Yahoo Finance • 14 days ago

Stocks Set to Open Higher as Bond Yields Fall, Trump’s Shutdown Talks in Focus

December S&P 500 E-Mini futures (ESZ25 [https://www.barchart.com/futures/quotes/ESZ25]) are up +0.48%, and December Nasdaq 100 E-Mini futures (NQZ25 [https://www.barchart.com/futures/quotes/NQZ25/overview]) are up +0.63% this morning, poin... Full story

Yahoo Finance • 14 days ago

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

Company Announcement Genmab to acquire Merus for USD 97.00 per share in an all-cash transaction representing a transaction value of approximately USD 8.0 billionProposed acquisition adds petosemtamab, a late-stage asset with two Breakthro... Full story

Yahoo Finance • 14 days ago

Genmab reportedly nearing deal to acquire cancer drug developer Merus

[M&A - concept waiting for mergers and acquisitions.3D rendering on yellow background.] Danish biotech Genmab (GMAB [https://seekingalpha.com/symbol/GMAB]) is in advanced discussions to acquire Merus (NASDAQ:MRUS [https://seekingalpha.com... Full story